EUVIMEDEUVIMED entdecken
Crossref

Attitudes face aux traitements inhalés en Algérie : refus initial et acceptation difficile

R S Benazzouz, M Benyagoub, M S Benazzouz, M Ould Setti

Revue des Maladies Respiratoires · 2026-05

DOI: 10.1016/j.rmr.2026.03.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revue des Maladies Respiratoires, 2026-05. Verfasst von R S Benazzouz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de médecine, université de Laghouat, Laghouat, Algérie. Electronic address: r.benazzouz@lagh-univ.dz. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To estimate the frequency of initial refusal of inhaled treatment in Algerian pneumology outpatients and to describe the characteristics of patients presenting this refusal. METHODS Multicenter cross-sectional study (September 2022 to January 2023) conducted in seven clinics. Attitudes were classified as immediate acceptance, difficult acceptance, or persistent refusal. Initial refusal combined the last two. RESULTS Three hundred eighty-five (385) patients were included (mean age 40.1±25.0 years; 49.9% male). Initial refusal occurred in 127/385 (33.0%), including 32/385 (8.3%) with persistent refusal; 95/127 (74.8%) accepted after discussion. Patients with initial refusal were younger, more often in a new initiation setting, and more likely to show poor disease acceptance. Immediate acceptance was more frequent when prescriptions included a long-acting beta-2 agonist or a fixed inhaled corticosteroid plus long-acting beta-2 agonist combination, and when the device was a capsule inhaler. It was also more frequent in patients previously exposed to inhaled therapy or with a close relative using an inhaler. Fears (adverse effects, dependence, stigma) and social influences were mainly reported by refusers; 54/127 (42.5%) cited close relatives as the main influence. Time devoted to information and advice was longer in the initial refusal group (6.39±3.33 vs. 4.00±2.00minutes). CONCLUSION One in three patients initially refuses inhaled therapy. Structured counselling at the time of prescribing, with attention to patients' beliefs and family influence, may help reduce these early refusals.

Schlagwörter

Stichwörter der Autor:innen

Adhésion thérapeutiqueAsthmaAsthmeBronchopneumopathie chronique obstructiveChronic obstructive pulmonary diseaseInhalation therapyMedication adherenceRefus de traitementTraitements inhalésTreatment refusal

Autor:innen und Institutionen

  • Faculté de médecine, université de Laghouat, Laghouat, Algérie. Electronic address: r.benazzouz@lagh-univ.dz.
  • Faculté de médecine, université de Laghouat, Laghouat, Algérie.
  • Institut Pasteur d'Algérie, Alger, Algérie; Faculté de pharmacie, université des sciences de la santé, Alger, Algérie.
  • Alma Mater Europaea - ECM, Vienne, Autriche; Observational Studies Germany, Real World Solutions, IQVIA, Francfort-sur-le-Main, Allemagne; Institute of Public Health and Clinical Nutrition, University of Eastern Finland…

Zitieren

APA

Benazzouz, R. S., Benyagoub, M., Benazzouz, M. S., & Ould Setti, M. (2026). Attitudes face aux traitements inhalés en Algérie : refus initial et acceptation difficile. Revue des Maladies Respiratoires. https://doi.org/10.1016/j.rmr.2026.03.002

Vancouver

Benazzouz RS, Benyagoub M, Benazzouz MS, Ould Setti M. Attitudes face aux traitements inhalés en Algérie : refus initial et acceptation difficile. Revue des Maladies Respiratoires. 2026. doi:10.1016/j.rmr.2026.03.002

BibTeX
@article{Benazzouz2026,
  author = {Benazzouz, R S and Benyagoub, M and Benazzouz, M S and Ould Setti, M},
  title = {Attitudes face aux traitements inhalés en Algérie : refus initial et acceptation difficile},
  journal = {Revue des Maladies Respiratoires},
  year = {2026},
  doi = {10.1016/j.rmr.2026.03.002}
}
Kostenlos starten →